TrialIntensive care medicine2020

Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial.

Parind B Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.